🇺🇸 Psyllium powder in United States

14 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 14

Most-reported reactions

1. Condition Aggravated — 2 reports (14.29%)
2. Haemorrhoids — 2 reports (14.29%)
3. Headache — 2 reports (14.29%)
4. Unevaluable Event — 2 reports (14.29%)
5. Abdominal Pain — 1 report (7.14%)
6. Agranulocytosis — 1 report (7.14%)
7. Alopecia Universalis — 1 report (7.14%)
8. Anxiety — 1 report (7.14%)
9. Appetite Disorder — 1 report (7.14%)
10. Arthritis — 1 report (7.14%)

Source database →

Frequently asked questions

Is Psyllium powder approved in United States?

Psyllium powder does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Psyllium powder in United States?

US Department of Veterans Affairs is the originator. The local marketing authorisation holder may differ — check the official source linked above.